About the company
Bioptimus is an AI-first biotech company building foundation models for biology, including a pathology model (H-Optimus) and a broader multi-scale, multi-modal biology model (M-Optimus). The company launched publicly with a $35M seed round in February 2024 and later announced a $76M funding milestone on January 14, 2025. Bioptimus positions the work around integrating biological data across scales, from molecules to tissues, to support research and innovation in biomedicine.